Trials / Not Yet Recruiting
Not Yet RecruitingNCT06739278
Individual Treatment of Ustekinumab in Perianal Fistulizing Crohn's Disease
Analysis for the Efficacy of Individual Treatment of Perianal Fistulizing Crohn's Disease With Ustekinumab
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 119 (estimated)
- Sponsor
- Second Affiliated Hospital of Wenzhou Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- —
Summary
This study intends to further explore the actual efficacy of ustekinumab in the individualized treatment of anal fistula Crohn's disease.
Detailed description
Participants in the study receive ustekinumab injections as part of routine medical care. The study just observes the efficacy retrospectively and does not interfere with treatment.
Conditions
Timeline
- Start date
- 2024-12-20
- Primary completion
- 2024-12-31
- Completion
- 2025-01-31
- First posted
- 2024-12-18
- Last updated
- 2024-12-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06739278. Inclusion in this directory is not an endorsement.